Belvedere Trading LLC Summit Therapeutics Inc. Call Options Transaction History

Belvedere Trading LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Jan 30, 2025	SELL	$17.52 - $23.46 $145,416 - $194,718	-8,300 Reduced 35.78%	14,900 $265,000
Q3 2024 Oct 30, 2024	SELL	$6.89 - $31.93 $16,536 - $76,632	-2,400 Reduced 9.38%	23,200 $508,000
Q2 2024 Nov 01, 2024	BUY	$2.39 - $10.92 $5,736 - $26,208	2,400 Added 10.34%	25,600 $199,000
Q2 2024 Aug 09, 2024	BUY	$2.39 - $10.92 $61,184 - $279,552	25,600 New	25,600 $199,000
Q3 2023 Oct 27, 2023	BUY	$1.54 - $2.42 $6,314 - $9,922	4,100 Added 1025.0%	4,500 $8,000
Q1 2023 May 15, 2023	BUY	$1.38 - $5.41 $552 - $2,164	400 New	400 $0

232

83.2M

1.66M

2.56M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.7B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.